Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

234.27
Delayed Data
As of Dec 02
 +14.02 / +6.37%
Today’s Change
117.58
Today|||52-Week Range
236.80
+38.15%
Year-to-Date

Today’s Trading

Previous close220.25
Today’s open217.52
Day’s range217.52 - 235.41
Volume44,875
Average volume (3 months)1,048,947
Market cap$28.8B
Data as of 4:00pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)+3.54%
Earnings growth (this year)-26.19%
Earnings growth (next 5 years)+38.33%
Revenue growth (last year)+71.31%
P/E ratioNM
Price/Sales23.79
Price/Book47.91

Competitors

----
HZNPHorizon Therapeutics...+3.95+3.91%
SGENSeagen Inc+1.48+1.22%
INCYIncyte Corp+2.54+3.15%
Data as of 4:00pm ET, 12/02/2022

Financials

Next reporting dateFebruary 9, 2023
EPS forecast (this quarter)-$1.83
Annual revenue (last year)$844.3M
Annual profit (last year)-$852.8M
Net profit margin-101.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts